Suchergebnisse - "1474-0338" OR "1744-764X"

PubPharm (4.936)

3481

Safety concerns with the long-term management of osteoporosis

enthalten in: Expert opinion on drug safety | 2013

von Reginster, J. | Pelousse, F. | Bruyère, O.

3482

Potential nephroprotective effects of l-carnitine against drug-induced nephropathy: a review of literature

enthalten in: Expert opinion on drug safety | 2013

von Jafari, A. | Dashti-Khavidaki, S. | Khalili, H. | +1

3483

Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis

enthalten in: Expert opinion on drug safety | 2013

von Scheen, A.

3484

The safety and efficacy of apixaban: where do we stand in 2013?

enthalten in: Expert opinion on drug safety | 2013

von de Souza Brito, F. | Lopes, R. | Alexander, J.

3485

Efficacy and safety of mipomersen sodium (Kynamro)

enthalten in: Expert opinion on drug safety | 2013

von Hovingh, K. | Besseling, J. | Kastelein, J.

3486

Safety evaluation of leflunomide in rheumatoid arthritis

enthalten in: Expert opinion on drug safety | 2013

von I Keen, H. | Conaghan, P. | Tett, S.

3487

2012 Annual Meeting of the Safety Pharmacology Society: spotlight on targeted oncology medicines

enthalten in: Expert opinion on drug safety | 2013

von Cavero, I.

3488

Related articles

enthalten in: Expert opinion on drug safety | 2013

3489

Related articles

enthalten in: Expert opinion on drug safety | 2013

3490

Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients : pooled analysis from 5 randomized studies

enthalten in: Expert opinion on drug safety | 2012

von Marcellin, P. | Roberts, S. | Reddy, K. | +8